523 related articles for article (PubMed ID: 33503302)
1. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS
Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
[TBL] [Abstract][Full Text] [Related]
2. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Xie L; Frech-Tamas F; Marrett E; Baser O
Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
[TBL] [Abstract][Full Text] [Related]
3. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
Kreutz R; Scholze J; Douros A
Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
[TBL] [Abstract][Full Text] [Related]
4. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
[TBL] [Abstract][Full Text] [Related]
5. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
Chrysant SG
Postgrad Med; 2011 Nov; 123(6):21-31. PubMed ID: 22104451
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
Axthelm C; Sieder C; Meister F; Kaiser E
Curr Med Res Opin; 2012 Jan; 28(1):69-78. PubMed ID: 22117838
[TBL] [Abstract][Full Text] [Related]
8. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
9. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
[TBL] [Abstract][Full Text] [Related]
10. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Punzi HA
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
[TBL] [Abstract][Full Text] [Related]
12. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan.
Wang X; Chen H; Essien E; Wu J; Serna O; Paranjpe R; Abughosh S
J Manag Care Spec Pharm; 2019 Jun; 25(6):678-686. PubMed ID: 31134857
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide.
Bramlage P; Ketelhut R; Fronk EM; Wolf WP; Smolnik R; Zemmrich C; Schmieder RE
Clin Drug Investig; 2014 Jun; 34(6):403-11. PubMed ID: 24719291
[TBL] [Abstract][Full Text] [Related]
15. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (± amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg.
Schweizer J; Ulmer HJ; Benduhn H; Klebs S
Curr Med Res Opin; 2011 Jan; 27(1):131-40. PubMed ID: 21117946
[TBL] [Abstract][Full Text] [Related]
17. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
Volpe M; de la Sierra A; Kreutz R; Laurent S; Manolis AJ
High Blood Press Cardiovasc Prev; 2014 Jun; 21(2):137-47. PubMed ID: 24532183
[TBL] [Abstract][Full Text] [Related]
18. Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.
Volpe M; de la Sierra A; Ammentorp B; Laeis P
Adv Ther; 2014 May; 31(5):561-74. PubMed ID: 24760656
[TBL] [Abstract][Full Text] [Related]
19. Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
Chrysant SG
Drugs Today (Barc); 2011 Mar; 47(3):197-206. PubMed ID: 21494697
[TBL] [Abstract][Full Text] [Related]
20. Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
Borghi C; Jayagopal PB; Konradi A; Bortolotto LA; Degli Esposti L; Perrone V; Snyman JR
Adv Ther; 2023 Apr; 40(4):1765-1772. PubMed ID: 36829102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
